Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Decisional Influences and IBD Patients' Medication Use
Status: Enrolling
Updated:  7/14/2011
Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
mi
from
Nashville, TN
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Decisional Influences and IBD Patients' Medication Use
Status: Enrolling
Updated: 7/14/2011
Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
Gastroenterology Group of Naples
mi
from
Naples, FL
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
University of Maryland Medical Center
mi
from
Baltimore, MD
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
South Jersey Gastroenterology
mi
from
Marlton, NJ
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
South Jersey Gastroenterology
mi
from
Marlton, NJ
Click here to add this to my saved trials
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated:  12/2/2011
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
Dose Escalation and Remission (DEAR)
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status: Enrolling
Updated: 12/2/2011
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated:  4/3/2012
Indiana University-Riley Hospital
mi
from
Indianapolis, IN
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated: 4/3/2012
Indiana University-Riley Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A Pilot Study for the Determination of Inter-observer Variation for Abnormalities Detected by Indigo Carmine Staining and Narrow Band Imaging Among Patients Undergoing Surveillance Colonoscopy for Ulcerative Colitis
Status: Enrolling
Updated:  5/23/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A Pilot Study for the Determination of Inter-observer Variation for Abnormalities Detected by Indigo Carmine Staining and Narrow Band Imaging Among Patients Undergoing Surveillance Colonoscopy for Ulcerative Colitis
Status: Enrolling
Updated: 5/23/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Managing Inflammatory Bowel Disease
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated:  6/12/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Managing Inflammatory Bowel Disease
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated: 6/12/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Vitamin D Treatment in Ulcerative Colitis
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated:  7/16/2012
Northshore
mi
from
Evanston, IL
Vitamin D Treatment in Ulcerative Colitis
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated: 7/16/2012
Northshore
mi
from
Evanston, IL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
The University of California, San Diego
mi
from
La Jolla, CA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Santa Monica Research Institute
mi
from
Santa Monica, CA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Santa Monica Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Western States Clinical Research Inc.
mi
from
Wheatridge, CO
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Western States Clinical Research Inc.
mi
from
Wheatridge, CO
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of Florida
mi
from
Gainesville, FL
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Shafran Gasteroenterology Center
mi
from
Winter Park, FL
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Shafran Gasteroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Health Science Research Center
mi
from
Pratt, KA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Health Science Research Center
mi
from
Pratt, KA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of Kentucky
mi
from
Lexington, KY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Medical Dental Complex
mi
from
Louisville, KY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Medical Dental Complex
mi
from
Louisville, KY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Midwest Center For Clinical Research
mi
from
Lee'S Summit, MO
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Midwest Center For Clinical Research
mi
from
Lee'S Summit, MO
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Long Island Clinical Research Assoc., Llp
mi
from
Great Neck, NY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Long Island Clinical Research Assoc., Llp
mi
from
Great Neck, NY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research Of Lima
mi
from
Lima, OH
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research Of Lima
mi
from
Lima, OH
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Pharma Resource
mi
from
East Providence, RI
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Pharma Resource
mi
from
East Providence, RI
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Nashville Medical Research Institute
mi
from
Nashville, TN
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Nashville Medical Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research Of San Antonio
mi
from
San Antonio, TX
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research Of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Fecal Microbiota Transplantation for Ulcerative Colitis
Evaluation of Durability of Fecal Microbiota Transplantation in Patients With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  12/3/2012
University of Washington
mi
from
Seattle, WA
Fecal Microbiota Transplantation for Ulcerative Colitis
Evaluation of Durability of Fecal Microbiota Transplantation in Patients With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 12/3/2012
University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease
Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease
Status: Enrolling
Updated:  12/5/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease
Prediction of Feeding Problems in Prostaglandin-dependent Prematurely Born Infants With Congenital Heart Disease
Status: Enrolling
Updated: 12/5/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Biloxi, MS
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Biloxi, MS
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Akron, OH
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Norman, OK
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Norman, OK
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Bristol, TN
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
Houston, TX
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials